Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005) Read more about Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005)
Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections Read more about Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis Read more about A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C Read more about Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C
NCI COVID-19 in Cancer Patients, NCCAPS Study Read more about NCI COVID-19 in Cancer Patients, NCCAPS Study
Feasibility of a Self-guided Exercise Program Among Hospitalized COVID-19 Patients Read more about Feasibility of a Self-guided Exercise Program Among Hospitalized COVID-19 Patients
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATL) Read more about Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATL)
Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo Read more about Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo
Reducing Time to Spaced-out Appointments for Newly-diagnosed People Living With HIV Read more about Reducing Time to Spaced-out Appointments for Newly-diagnosed People Living With HIV